CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +107,000 | 107,000 | ||
| 2024-12-01 | Walker Neal INTERIM CEO | Option exercise | +9,466 | 1,385,854 | ||
| 2024-12-01 | Walker Neal INTERIM CEO | Shares withheld for taxes | −2,721 | $4.07 | $11K | 1,383,133 |
| 2024-12-01 | Walker Neal INTERIM CEO | Option exercise · Restricted Stock Units | −9,466 | 47,334 | ||
| 2024-11-19 | Mehra Anand Director | Purchase | +666,666 | $2.25 | $1.5M | 710,030 |
| 2024-11-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise | +9,467 | 1,379,109 | ||
| 2024-11-01 | Walker Neal INTERIM PRESIDENT AND CEO | Shares withheld for taxes | −2,721 | $2.09 | $6K | 1,376,388 |
| 2024-11-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −9,467 | 56,800 | ||
| 2024-10-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise | +9,467 | 1,372,364 | ||
| 2024-10-01 | Walker Neal INTERIM PRESIDENT AND CEO | Shares withheld for taxes | −2,722 | $1.18 | $3K | 1,369,642 |
| 2024-10-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −9,467 | 66,267 | ||
| 2024-09-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,000 | 24,983 | ||
| 2024-09-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −286 | $1.18 | $337 | 24,697 |
| 2024-09-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,000 | 0 | ||
| 2024-09-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise | +9,466 | 1,365,619 | ||
| 2024-09-01 | Walker Neal INTERIM PRESIDENT AND CEO | Shares withheld for taxes | −2,722 | $1.18 | $3K | 1,362,897 |
| 2024-09-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −9,466 | 75,734 | ||
| 2024-08-09 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise | +43,548 | $0.72 | $31K | 1,356,153 |
| 2024-08-09 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise · Employee Stock Option (right to buy) | −43,548 | 0 | ||
| 2024-08-05 | Leonard Braden Michael 10% owner | Purchase | +206,025 | $1.24 | $256K | 14,250,000 |
Page 11 of 34 · 680 trades